Last edition
News about "Karl Pinto"
GBI Biomanufacturing has partnered with NanoRetinal to advance development and manufacturing of NAR-001, a novel nanoparticle therapy for Inherited Retinal Diseases.
Karl Pinto | 10/09/2025 | By Mrinmoy Dey | 139
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members